PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1485728
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1485728
Structural Biology & Molecular Modelling Techniques Market size was valued at USD 2,764.43 Million in 2023, expanding at a CAGR of 20.5% from 2024 to 2032.
The structural biology and molecular modeling techniques market involves the study of molecular structures and interactions to understand biological processes and facilitate drug discovery. Advancements in computational biology, protein structure determination technologies, and increased demand for targeted therapies in pharmaceutical research, alongside the rise of personalized medicine and precision drug design, are driving the market growth. However, challenges include limitations in computational resources for complex simulations and high costs associated with equipment and software required for structural biology and molecular modeling studies. Despite these challenges, the market's potential for growth is driven by ongoing research in structural biology and the increasing focus on personalized healthcare solutions.
Structural Biology & Molecular Modelling Techniques Market- Market Dynamics
Rising clinical urgency fuels structural biology & molecular modeling market growth
The increasing prevalence of chronic diseases, often with acquired drug resistance, underscores the critical need for developing new and advanced therapeutics. This clinical urgency has propelled the incorporation of structural biology and molecular modeling techniques into drug discovery and development processes, aiming to create a new generation of effective drugs. For instance, initiatives like the U.S. National Institutes of Health (NIH) Molecular Libraries Program leverage structural biology and computational modeling to identify potential drug targets and design novel compounds. Similarly, pharmaceutical companies like Pfizer and Novartis utilize these techniques to optimize drug candidates and improve therapeutic outcomes, highlighting the growing importance of structural biology and molecular modeling in addressing complex medical challenges and advancing personalized medicine initiatives.
Structural Biology & Molecular Modelling Techniques Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 20.5% over the forecast period (2024-2032)
Based on Tools segmentation, Computational was predicted to show maximum market share in the year 2023
Based on Technique segmentation, X-ray Crystallography was the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Structural Biology & Molecular Modelling Techniques Market is segmented based on Tools, Techniques, Application, and Region.
The market is divided into four categories based on Tools: SaaS & Standalone Modeling techniques, Visualization, Databases, and Analysis. Databases are highly preferred as they provide a foundational resource for researchers and drug discovery efforts. Analysis tools enable researchers to perform statistical analyses, identify patterns, and extract meaningful insights. Researchers use visualization software to analyze and interpret biological data visually. Software as a Service enables researchers to predict and simulate molecular structures, aiding in drug design and molecular analysis.
The market is divided into five categories based on Technique: Structural biology and molecular modeling techniques, NMR spectroscopy, Cryo-EM, and mass spectrometry, computational modeling. NMR Spectroscopy is widely preferred for studying molecular structures and dynamics in solution. Cryo-EM is a powerful technique for visualizing macromolecular structures at near-atomic resolution. Mass Spectrometry: Important for protein identification, characterization, and quantification by analyzing mass-to-charge ratios of ionized molecules. Computational modeling is utilized for predicting protein structures, molecular interactions, and dynamics using algorithms and simulations.
Structural Biology & Molecular Modelling Techniques Market- Geographical Insights
North America, particularly the United States, dominates the market due to its strong research infrastructure, advanced technological capabilities, and robust pharmaceutical industry. In Europe, countries like the UK, Germany, and Switzerland are key players, driven by substantial government funding for research and development in biotechnology and healthcare. Asia-Pacific is also emerging as a growing market for structural biology and molecular modeling, with countries like China and Japan investing in research and fostering innovation in drug discovery and personalized medicine.
Several key players such as Schrodinger, Dassault Systemes, and Biovia Corporation, are known for their expertise in computational modeling software and solutions. These companies offer advanced tools for drug discovery, protein engineering, and molecular design, catering to the pharmaceutical, biotechnology, and academic research sectors. Recent product innovations include Schrodinger's LiveDesign platform, which enables real-time interactive molecular design for optimizing drug discovery processes. Other notable players in the market include Accelrys (now part of Dassault Systemes) and OpenEye Scientific Software, reflecting a competitive landscape focused on innovation and technological advancements in structural biology and molecular modeling.
In June 2023, Inventia is expanding globally into the Indian market by establishing a distribution agreement with Biotron Healthcare PVT Ltd for its product RASTRUM.
In November 2023, Elsevier formed a partnership with the Korean Society for Molecular and Cellular Biology to publish molecules and cells.
GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELLING TECHNIQUES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Bruker Corporation
Waters Corporation
PerkinElmer, Inc.
Shimadzu Corporation
Rigaku Corporation
JEOL Ltd.
Genedata AG
Schrodinger, Inc.
Molecular Operating Environment (MOE)
OpenEye Scientific Software, Inc.
BioSolveIT GmbH
Cresset Group Ltd.
Certara, L.P.
Dassault Systemes BIOVIA
Others